November Virginia Bioscience Commercialization Luncheon
Mid-Term Election Wrap Up 2022
Mid-Term Election Wrap Up 2022
The Center for Breakthrough Medicines (CBM) offers comprehensive AAV testing services with the newly launched Analytical AcceleratorTM for AAV Testing. Given recent gene therapy approvals and a growing clinical pipeline, there is currently a severe shortage of Good Manufacturing Practices (GMP) testing capacity for AAV-based gene therapies, resulting in extremely long leads for key assays, …
MDMA’s 25th Annual Reimbursement & Health Policy Conference November 9-10,
Learn from industry leaders in healthcare and biotech information that you can share with students and job-switchers as they seek advice and guidance on their career paths and to draw attention to the wide variety of well-paying positions that are in high demand in Health & Life Sciences in the Roanoke and New River Valleys, …
Join us for the second in our IP Webinar series. Dr. Judy de León Jarecki-Black, Senior Counsel in the Intellectual Property Practice of Smith, Gambrell & Russell, LLP. will present on “Developing and implementing an IP strategy in the biotech space”.
Join us to learn about the Hampton Roads Biomedical Research Consortium (HRBRC), a state-sponsored partnership between Old Dominion University, Eastern Virginia Medical School, Sentara Healthcare, and Norfolk State Univercity that is addressing health disparities, jumpstarting scientific research, and building a biohealth vertical for the region. Hear from members of the consortium and learn how …
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will …
Join us as we kick-off the Virginia Catalyst Life Science Conference. (Please use code VABioOct2022 when registering for only the networking reception)
2022 CEA Summit East The Controlled Environment Agriculture Innovation Center (VT-IALR CEA-IC), a partnership between the School of Plant and Environmental Sciences at Virginia Tech and Virginia Seafood Agricultural Research and Extension Center at Virginia Tech and the Institute for Advanced Learning and Research, and Indoor Ag-Con invite you to participate in the first CEA …
Join us for the first in our IP Webinar series. Jessica Roberts, Attorney at Finnegan will present on “Knowing the Patent Landscape” to discuss the scope and value of landscape analyses, reducing risks with FTO, and strategic patent prosecution to create stronger patents, including case examples in the biotech field. Jessica has broad experience in …
Game Changer Week September 13-15, 2022 | Roanoke and Blacksburg, Virginia Game Changer Week (GCW) celebrates our innovative ecosystem where participants are inspired by encounters with disruptors from all industries, people of all ages with ideas, the curious looking to learn or invest, and the brightest talent among us. Participants – no matter the career or business …
Join Us to Discuss the Importance of SBIR/STTR Reauthorization Please join a special briefing to discuss the critical importance of SBIR/STTR programs as economic drivers that support American innovation and small businesses. On September 13, AdvaMed, BIO, and CSBA will host a special briefing to discuss the success of SBIR/STTR programs, their economic impact, and …
The 8th International Symposium on Focused Ultrasound is the world’s leading forum for clinical and scientific experts to share the latest advances in focused ultrasound. The meeting is an opportunity to reflect on the remarkable progress in the field and chart a clear roadmap forward. We feel the technology has never been more poised for …
CvilleBioHub is hosting our first ever BioDiscovery Summit! The program includes short and exciting updates from companies in our ecosystem and a Keynote Conversation on intellectual property with Derrick Brent, Deputy Director of the United States Patent and Trademark Office and a Keynote Presentation from Dr. Marc Hedrick, President and CEO at PLUS …
You are invited to register for the hybrid 2022 Technology Showcase on September 7. This annual event, planned by the National Cancer Institute’s Technology Transfer Center, in partnership with the Frederick National Laboratory (FNL), is designed to encourage licensing and collaboration of select NCI and FNL inventions. Companies, entrepreneurs, innovators, foundations, philanthropies, economic development entities, …
Virtual Reality + Healthcare Technology Transfer Conference Researchers at universities nationwide are building virtual and extended reality (VR/XR) applications for use in healthcare — to better detect, diagnose, and treat medical conditions and improve quality of life. But how do we further develop those inventions into real-world applications? This two-day VR & Healthcare Technology Transfer Conference, held …
In partnership with Virginia Bio, ICAP is continuing its presentation series on important topics related to Virginia’s life science startups. These presentations are a great opportunity to help founders expand their knowledge base, offer support and lessons learned from experienced ICAP Mentors, network with other startups, as well as introduce them to a number of resources from around the Commonwealth. Tuesday, …
Virginia Bio Commercialisation Luncheon is back! On September 8, we will discuss Sustainability and Carbon Emissions Monetization Opportunities with Krish R Krishnan CEO, and Dr. Gitanjali Baveja, Chief Medical Officer of ZASTI Join us to hear about some basic opportunities for companies to initiate their own strategies for decarbonization.
LEGISLATIVE BRIEFING The Transformative Potential of Gene Therapies Monday September 12, 12:00 PM (Lunch at 11:30 AM) In Person-VA Bio+Tech Park, Founder’s Room & Virtual- Zoom COVID-19 has changed the world in many ways. As we continue to emerge from the pandemic, innovative companies are resuming work on novel cell and gene therapies. These …